MEDEZE Welcomes Thai VI, Showcasing the Strength of Its Stem Cell Business Highlighting Regenerative Medicine Growth Opportunities to Support the Health Economy | MEDEZE Investor Relation (MEDEZE)

16.07.2026

MEDEZE Welcomes Thai VI, Showcasing the Strength of Its Stem Cell Business Highlighting Regenerative Medicine Growth Opportunities to Support the Health Economy

MEDEZE Welcomes Thai VI, Showcasing the Strength of Its Stem Cell Business Highlighting Regenerative Medicine Growth Opportunities to Support the Health Economy

Dr. Veerapol Khemarangsan,Chief Executive Officer; Mr. Piyawat Ratchapolsit, Vice Chairman; and Dr. Vasawat Sroithong, Investor Relations Officer of MEDEZE Group Public Company Limited (MEDEZE), welcomed representatives from the Thai Value Investor Association (Thai VI) during their company visit.

MEDEZE is Thailand’s only legally compliant and certified stem cell bank, providing comprehensive stem cell and immune cell banking services. With extensive experience and expertise accumulated over many years, the Company has established itself as a leading provider of personalized stem cell banking services in Southeast Asia.

The Company operates in accordance with internationally recognized standards, including ISO 9001:2015 certification and AABB accreditation. It also utilizes proven technologies, including the AXP AutoXpress® Platform and cryopreservation technology, to ensure precision and safety throughout every stage of cell processing and storage. Its services cover cord blood, cord tissue, adipose tissue, hair follicles, and Natural Killer (NK) Cells, supporting a wide range of long-term healthcare plans.

During the visit, MEDEZE’s executives shared the Company’s experience and vision as a leading provider of stem cell banking and cell cultivation services. They also highlighted the potential role of cell therapy and regenerative medicine technologies in advancing Thailand’s healthcare industry and creating new growth opportunities for the health economy.

The Company also presented an overview of its businesses and services, including its collaboration with the Government Pharmaceutical Organization (GPO) and Cretan Associates Co., Ltd. to establish GPO MEDEZE Empower Co., Ltd.

The visiting delegation was given a tour of MEDEZE’s certified laboratories and cell storage facilities, providing an opportunity to gain first-hand insight into the Company’s operational processes and advanced medical technologies.

The visit took place at the headquarters of MEDEZE Group Public Company Limited on Phutthamonthon Sai 4 Road.

For more information, please visit: https://www.medezegroup.com/en/

IR Press Releases

MEDEZE Welcomes Thai VI, Showcasing the Strength of Its Stem Cell Business Highlighting Regenerative Medicine Growth Opportunities to Support the Health Economy

MEDEZE and Chulalongkorn University Announce Successful Project Completion and Technology Transfer for Recombinant Protein Production Supporting the Future Growth of Thailand’s ATMP and Cell Therapy Industries MEDEZE and Chulalongkorn University Announce Successful Project Completion and Technology Transfer for Recombinant Protein Production Supporting the Future Growth of Thailand’s ATMP and Cell Therapy Industries

MEDEZE Joins Forces with the Government Pharmaceutical Organization and Cretan Associates Establishes “GPO MEDEZE Empower Co., Ltd.” with Registered Capital of THB 105 Million Elevating Thailand’s Biomedical Industry Toward Becoming a Regional ATMPs Production Hub

Dr. Veerapol Khemarangsan Shares Expertise at AMRAS 2026 International Congress, Showcasing Thailand’s Excellence in Minimally Invasive Gynecologic Surgery

A Turning Point in Building Confidence in Advanced Medicine As Thailand’s Stem Cell Industry Enters an Era of Regulatory Standards and Legal Recognition

“MEDEZE” Showcases Strong Stem Cell Business Performance in Q1 2026 at Earnings Call (Opp Day) Advancing Research and Expanding Franchise Network to Drive Long-Term Growth

MEDEZE Acknowledges Royal Gazette Announcement on Cell Bank Standards Becomes Thailand’s First Certified Cell Bank, Reinforcing Leadership in Advanced Medical Technologies

MEDEZE Showcases Stem Cell Innovations at ALES 2026 Highlighting the Vision for the Future of Healthcare

MEDEZE Holds 2026 Annual General Meeting of Shareholders via E-AGM All Agenda Items Approved; Dividend Payment of THB 0.08 per Share Announced

MEDEZE Holds 2026 Annual General Meeting of Shareholders via E-AGM All Agenda Items Approved; Dividend Payment of THB 0.08 per Share Announced

MEDEZE Welcomes Thammasat University Students for Study Visit on Stem Cell Innovation, Inspiring the Future of the Healthcare Industry

Dr. Veerapol Khemarangsan Advances Modern Medical Knowledge at International Academic Conference Hosted by Charoenkrung Pracharak Hospital

MEDEZE Joins the Grand Opening of “VAANAA Longevity Chiang Mai,” Supporting Thailand’s Rise as a High-End Wellness Destination

MEDEZE Welcomes WHB Programme Delegation for Business Visit, Showcasing Thailand’s Stem Cell Potential on the Global Stage

MEDEZE Congratulates the Launch of the “Menopause Wellness” Center At Phyathai 1 Hospital, Advancing Comprehensive Care for Menopausal Women

MEDEZE Joins Focus Group for NDC Class 68 Highlighting Opportunities in the Healthcare Business and Advanced Medical Technologies

MEDEZE Reinforces Its Position as a Leader in Future Medical Innovation Wins “The Most Innovative” Award at Future Trends Awards 2026

MEDEZE Shares Future Healthcare Business Vision at the WHB Program by IWH Academy

MEDEZE Showcases Performance at Opportunity Day Year-End 2025 Aiming to Create a New S-Curve from ATMPs

MEDEZE Reports 2025 Net Profit of THB 196 Million with Revenue of THB 776 Million Confident in International Standards and Advanced Medical Trends to Drive Future Growth

MEDEZE Showcases Advanced Medical Innovation and Biobank Solutions for Women’s Health at OBGYN in Practice 2026

“MEDEZE Group” Participates in International Academic Conference to Explore Market Expansion and New Partnership Opportunities in Nigeria

Thai FDA Supports the Advanced Medical Industry by Hosting FDA EXPO 2026, Driving Thailand’s ATMPs onto the Global Stage; MEDEZE Showcases Its Comprehensive ATMP Sandbox Capabilities

MEDEZE Welcomes the Dental Innovation Foundation for Knowledge Exchange on Medical Innovation

MEDEZE Welcomes World NexGen 2026, Strengthening an International Network of Next-Generation Leaders in the Health Economy

MEDEZE Participates in Thailand ATMP Roadmap 2025, Reinforcing Its Role in Advancing Thailand’s Advanced Medical Industry

MEDEZE Wins Frost & Sullivan 2025 Award, Reinforcing Its Leadership in Stem Cell and Advanced Medical Innovation in Southeast Asia

MEDEZE Partners with Identity Dermatology Center, Signs MOU to Advance Regenerative Beauty Innovation and Position Thailand as a Medical & Wellness Tourism Hub

MEDEZE Targets 25% Growth in 2026, Accelerates Full-Scale Expansion into the Health Economy Partners with GPO to Establish a Joint Venture for Cell Culture Media Production, Upgrading from Biobank to Biopharma, While Advancing the JUMP+ Program to Strengthen Healthcare Capabilities and Sustainable Growth

“MEDEZE” Ready to Move Forward in Line with Government Policy, Driving Advanced Medical Products Across All Dimensions

MEDEZE Shares Knowledge, Welcomes NIDA Faculty and Students for Corporate Visit

MEDEZE Shares Vision on “Thailand Next Growth Engines” at FOLLOW THE FUTURE 2025

MEDEZE Congratulates S Spine & Joint on Its Grand Opening Strengthening Its Role as a Next-Generation Health Organization Elevating Quality of Life for Thai People

MEDEZE Demonstrates Strong Q3/2025 Performance with THB 160 Million Net Profit Advances Toward Becoming “Thailand’s First ATMPs” and Strengthens Its Position as a Regional Medical Leader

MEDEZE Achieves Nearly THB 160 Million Net Profit in 9M/2025 “ATMPs Sandbox” Marks a Milestone in Advancing Hope for Disease Treatment

“MEDEZE” Advances Stem Cell Knowledge — Participates as Speaker at the 40th Annual Scientific Meeting of the Royal Thai College of Obstetricians and Gynaecologists

“MEDEZE” Shares Insights on “Stem Cell Innovation” at Yuanta Seminar Transforming Healthcare into the Investment Frontier of the Future

MEDEZE Participates in “Future Ready Beyond 2025” Seminar Highlighting Health and Technology Trends on a National Investment Stage

MEDEZE เข้าตามหลักเกณฑ์รับรองมาตรฐาน “ธนาคารเซลล์" ขานรับประกาศ “ราชกิจจาฯ” เดินหน้าสู่ผู้นำธุรกิจสุขภาพแห่งอนาคต

MEDEZE Participates in “The 3rd National Forum on Continuing Medical Education” Reaffirming Its Leadership in Next-Generation Medical Innovation

MEDEZE Welcomes KH Academy Enhancing Knowledge and Fostering Innovation in Future Medical Science

“MEDEZE” คว้ารางวัล “ธุรกิจด้านสุขภาพยอดเยี่ยมแห่งปี” ตอกย้ำผู้นำด้านนวัตกรรมสุขภาพสู่เป้าหมาย “HEALTH Economy” แห่งอนาคต

“MEDEZE” Joins as a Guest Speaker at “Bumrungrad Care for Children 2025” Reaffirming Its Role as a Regional Leader in Health Innovation

“MEDEZE” Welcomes Students from the Thammasat–Suksasongkroh School Science Program (WMW–TU–Skr) Inspiring the Next Generation Toward Advanced Medical Science

“MEDEZE Reinforces Its Leadership in Stem Cell Innovation Across Southeast Asia — Welcomes Indonesian Investors on an Exclusive Visit”

MEDEZE Welcomes Bumrungrad Executives, Showcasing World-Class Laboratory Capabilities to Drive Healthcare Innovation in Southeast Asia

MEDEZE Reinforces Its Role as a Leader in Advanced Medical Business by Joining the Panel Discussion: ‘Preparing for the Great Crisis: Decoding the World’s Game

MEDEZE Joins the ‘Market’s New Magnet’ Forum to Share Its Vision as a Leader in the New Global Business Era, Reinforcing Its Commitment to Driving Future Health Innovations.

MEDEZE Achieves a Score of 86 in the 2025 AGM Checklist, Reinforcing Its Corporate Governance Standards.

MEDEZE Showcases First-Half 2025 Performance and Advances the ‘Sandbox’ Initiative to Develop Next-Generation Therapeutic Products.”

MEDEZE ทำกำไรครึ่งปี 68 ที่ 129 ลบ. รายได้รวม 408 ลบ. เดินหน้า “Sandbox” ต่อยอดผลิตภัณฑ์ยาเพื่อการบำบัดรักษาขั้นสูง

MEDEZE Participates in the 7th SMART Conference, Elevating Thai Aesthetic Medicine to Global Standards

“MEDEZE” ฉลอง 15 ปีสุดยิ่งใหญ่ “Future of Thailand HEALTH Economy” รวมพลังขับเคลื่อนเศรษฐกิจไทยด้วยการแพทย์แห่งอนาคต

MEDEZE ฉลอง 15 ปี อย่างยิ่งใหญ่ เดินหน้า “Sandbox” รวมพลังการแพทย์ไทยขับเคลื่อนเศรษฐกิจสู่ “HEALTH Economy”

"MEDEZE” ต้อนรับนักวิเคราะห์และนักลงทุนจาก CGSI และ KKPFG ร่วมเจาะลึกอนาคตการแพทย์ระดับโลก

"MEDEZE โชว์ศักยภาพแพทย์ไทย ร่วมประชุมวิชาการ AAHRS 2025 ตอกย้ำผู้นำด้านการฟื้นฟูเส้นผมระดับภูมิภาค

“MEDEZE” Welcomes Dr. Khao, Researcher from the National Center for Genetic Engineering and Biotechnology (BIOTEC)

“MEDEZE” Extends Congratulations at the Grand Opening of “KLS Kasemrad Liposuction and Slimming Center BY La Ferly”

“MEDEZE” Welcomes General Lertrat, Who Banks Adipose-Derived Stem Cells as Part of His Long-Term Health Strategy

“MEDEZE” Reinforces Its Role as Thailand’s Leading Stem Cell Bank, Reports Soaring Profit in Q1/2025

“MEDEZE” Advances Preparations to Renovate the Premises and Visits the ATMPs Sandbox Project at the Bangrak Medical Center Building

TIME Magazine Features MEDEZE GROUP and Showcases the Vision of Dr.Veerapol as a Regional Representative in the New Era of Sustainable Medicine

“MEDEZE” Hosts “Biolongevity: Technology for Longevity” in the Lao People's Democratic Republic, Aiming to Become a Regional Biotech Leader in CLMVT

MEDEZE Participates in ISO 20387:2018 Training to Elevate Biobanking Standards

"One Stem Cell Equals Medicine" — Ministry of Public Health, Vachira Phuket Hospital, and MEDEZE Group Join Forces to Advance the ATMPs Sandbox, Paving the Way for the Future of Advanced Thai Medicine

A Closer Look: Danita Phitaknetikul and Her Daughter Visit for Hair Root Touch-Up

“MEDEZE” Welcomes CEO of BHI Clinic for a Visit to Asia’s First Hair Follicle Cell Cryopreservation Technology

MEDEZE Enhances Executive Leadership with the Appointment of Mr. Piyawat Rachpolsit as Vice Chairman, Aiming to Drive Strategic Growth in the Global Healthcare Sector

"MEDEZE Announces 1Q2025 Performance Results, Continues to Execute Ongoing Growth Strategy"

MEDEZE shows the first curve of profit in 2025, growing 27%, revenue growing by 20%. High demand for stem cell storage supports every business to expand.

Southeast Asian stem cell leader Medeze launches voluntary conditional cash partial offer for 10% stake in SGX-listed Cordlife Group Limited

"MEDEZE had the pleasure of welcoming clients from IFCG and provided them with detailed information on NK Cells, aiming to enhance in-depth medical knowledge."

MEDEZE จัดประชุมสามัญผู้ถือหุ้นประจำปี 2568 ผ่านสื่ออิเล็กทรอนิกส์ E-AGM ผถห.อนุมัติไฟเขียวทุกวาระ ตอกย้ำผลประกอบการโตอย่างต่อเนื่อง

MEDEZE Welcomes Executives from ‘Khongkwan Clinic’ to Explore Opportunities for Advancing Healthcare Business through Medical Innovation

“MEDEZE” เติมเต็มความสุขสุดเอ็กซ์คลูซีฟ ชวนลูกค้าคนพิเศษร่วมชม “Snowwhite”

MEDEZE Welcomes ABRM Executive Delegation for Discussions on Advancing Collaboration in Medical Innovation

“MEDEZE” Hosts an Official Visit for the Nursing Team from Rama 9 Hospital to Explore Its Operations

"MEDEZE" showcases its business potential at Opp Day Year End 2024.

"MEDEZE" celebrates the 2nd anniversary of "The Fountain of Youth."

"MEDEZE" explores the Health Care business in-depth at the Mitihoon Seminar.

MEDEZE Targets Record-High Revenue of Over 1 Billion THB in 2025 Invests 552 MB Acquiring Land for New Cell Bank to Support Expansion

"MEDEZE" presents its business outlook at the Analyst Meeting Year-End 2024.

"MEDEZE" delivered a special presentation at the grand opening of "VANA Longevity Clinic (Bangsaen)."

"MEDEZE" Signs MOU to Launch a Stem Cell Bank in the Philippines

“MEDEZE” and “IFGC” hosted Unlock the Miracle Inside You to reveal the secrets of stem cells, boosting immunity, and protecting against harmful diseases.

"Mediz Group" welcomes the CEO of Bitkub and Frost & Sullivan Executives.

MEDEZE Unveils “Hair Renaissance” Asia’s First Hair Follicle Cryopreservation Bank

"MEDEZE discusses opportunities to open a stem cell bank and visits the Ministry of Health, Manila, Republic of the Philippines."

"MEDEZE" welcomes CSI Investment Institute for a company visit.

MEDEZE x IFCG signing MOU to expand consultants network targeting high purchasing power customers.

MEDEZE Partners with IFCG, Signing MOU to Expand Sales Network Targeting High-Purchasing Power Clients

“MEDEZE” welcomes the Government Pharmaceutical Organization with an open house.

"MEDEZE" Explores Business Opportunities in Oman for Future Growth

"MEDEZE" Showcased Vision at "Follow The Future 2024 – UNRAVEL THE NEW ERA: Decoding the New World"

MEDEZE Signs Agreement with SHIBUYA for Automatic Cell Cultivation System A Smart Solution to Enhance the New Cell Bank Capabilities, Delivery Expected by June 2026

MEDEZE Wins the 'ACES Award' Recognized for Setting Outstanding Standards in Stem Cell Storage and Care

"MEDEZE" Participated in the 46th Annual Royal College of Orthopaedic Surgeons of Thailand Meeting

MEDEZE Opens on First Trading Day at 13.30 THB, Up 47.78% from IPO Price Pushes Forward with Business Expansion, Reinforcing Industry Leadership

"MEDEZE" Debuts on First Trading Day at 13.30 Baht, 47.78% Above IPO Price

"MEDEZE" Roadshow Provided In-Depth Business Insights on Yuanta Corporate Day

"MEDEZE" Presented to VI Investors, Showcasing Its Potential as a Leader in Stem Cells and Biotech in Thailand

"MEDEZE" Roadshow at the Stock Exchange Showcased Strong Fundamentals, Boosting Investors’ Confidence

MEDEZE Appoints Yuanta Securities as Underwriter Sets IPO Price at 9 Baht per Share, Subscription Period from October 2 – 4, 2024

"MEDEZE" Southern Roadshow in Songkhla Showcasing Strong Business Highlights

"MEDEZE" Expanded to the Northeast to Showcase Business Potential and Present to Investors in Udon Thani

"MEDEZE" Presented to Investors in Chiang Mai, Prepares for IPO Offering to List on SET

"MEDEZE" Presented to Investors in Preparation for IPO Offering to List on SET

ก.ล.ต. นับหนึ่งไฟลิ่ง “เมดีซ กรุ๊ป” ขาย IPO 268 ล้านหุ้น ขยายธุรกิจเซลล์รากผม ระบบจัดเก็บเซลล์ด้วยหุ่นยนต์

"MEDEZE" Hosted Analyst Meeting to Showcase Business Potential Ahead of IPO Offering of 268 Million Shares

The SEC and the SET Visited "MEDEZE" Operations

MEDEZE Welcomed the Ambassador of Oman to the Kingdom of Thailand